NCT07214129View on ClinicalTrials.gov

Safety and Efficacy of Nebulized Nitroglycerin in Pulmonary Arterial Hypertension

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2024

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Nebulized nitroglycerin

Nebulized nitroglycerin as vaso-reactive agen in pulmonary arterial hypertension

Trial Locations (1)

35516

Mohamed AbdElmoniem, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER